Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesMRIStudy affirms MRE as quantitative imaging biomarkerLiver stiffness measurements agree between conventional MR elastography sequence and updated sequence, according to researchers.UltrasoundPediatric CEUS use 'slowly' rising since FDA clearanceAIAI aging estimates based on chest x-rays linked to mortalityUltrasoundUltrasound MinnieCast, Episode 5: How POCUS is reshaping careSponsor ContentModernizing Radiotherapy Workflows
